Pharming launches Joenja (leniolisib) commercially in Japan
Pharming announces the commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.